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Abstract
Background: Observational outcome studies of patients with obstructive sleep apnea (OSA)
require adjustment for co-morbidity to produce valid results. The aim of this study was to evaluate
whether the combination of administrative data and self-reported data provided a more complete
estimate of co-morbidity among patients referred for sleep diagnostic testing.
Methods: A retrospective observational study of 2149 patients referred for sleep diagnostic
testing in Calgary, Canada. Self-reported co-morbidity was obtained with a questionnaire;
administrative data and validated algorithms (when available) were also used to define the presence
of these co-morbid conditions within a two-year period prior to sleep testing.
Results: Patient self-report of co-morbid conditions had varying levels of agreement with those
derived from administrative data, ranging from substantial agreement for diabetes (κ = 0.79) to
poor agreement for cardiac arrhythmia (κ = 0.14). The enhanced measure of co-morbidity using
either self-report or administrative data had face validity, and provided clinically meaningful trends
in the prevalence of co-morbidity among this population.
Conclusion: An enhanced measure of co-morbidity using self-report and administrative data can
provide a more complete measure of the co-morbidity among patients with OSA when agreement
between the two sources is poor. This methodology will aid in the adjustment of these coexisting
conditions in observational studies in this area.
Background
Obstructive Sleep Apnea (OSA) is a disorder characterized
by periods of cessation of breathing during sleep with
intermittent hypoxemia and sleep fragmentation. Popula-
tion-based studies estimate the prevalence of OSA to be
approximately 3 to 7% for adult males and 2 to 5% for
adult females in the general population [1-4]. Further-
more, patients with OSA commonly have other medical
conditions, including hypertension, stroke, cardiovascu-
lar disease, and cardiac arrhythmia [5-14].
Given the increased morbidity associated with OSA,
observational studies of patients with OSA must also
adjust for these co-morbid conditions to determine the
Published: 15 July 2009
BMC Medical Research Methodology 2009, 9:50 doi:10.1186/1471-2288-9-50
Received: 5 March 2009
Accepted: 15 July 2009
This article is available from: http://www.biomedcentral.com/1471-2288/9/50
© 2009 Ronksley et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Research Methodology 2009, 9:50 http://www.biomedcentral.com/1471-2288/9/50
Page 2 of 9
(page number not for citation purposes)
independent effect of OSA on the outcomes of interest.
The use of self-reported data through questionnaires or
interviews is a common method of determining the pres-
ence of co-morbid conditions due to its efficiency and rel-
ative low cost. However, the reliability and accuracy of
this data is questionable [15-21]. In addition the validity
of self-reported conditions, using medical records as the
gold standard, varies depending on the medical condi-
tions in question and the target population under investi-
gation [15-21].
Administrative data is another source from which to
determine the presence of co-morbid conditions. While
agreement between self-reported medical conditions and
that obtained from administrative databases also varies
[22-27], combining self-reported clinical data with that
obtained from administrative data has been proposed as
a method to increase the completeness and accuracy of co-
morbid conditions [28-30]. This enhanced measure of co-
morbidity has been undertaken and shown to provide a
valid assessment for patients with coronary heart disease
and those undergoing coronary artery bypass graft surgery
[31-33]. Previous studies have assessed co-morbidity in
OSA patients in the years prior to diagnosis [34,35]. How-
ever, many of these studies have relied on administrative
records alone to determine co-morbidity. This source
alone may result in an underestimate of co-morbidity
within these populations. Given the importance of co-
morbidity in observational studies of OSA patients, and
the limited information in the literature on studies com-
bining data sources to measure co-morbidity, the purpose
of this study was to evaluate whether the combination of
administrative data and self-reported data provided a
more complete estimate of co-morbidity among patients
referred for sleep diagnostic testing.
Methods
Study Design
This project is part of a larger retrospective study investi-
gating health care utilization among patients with OSA.
We included all adult patients (> 18 years old) referred for
sleep diagnostic testing at either a hospital location in Cal-
gary, Alberta, or private home care facilities within the
Calgary Health Region between July 2005 to August 2007.
Virtually all sleep diagnostic testing for the city of Calgary
and surrounding areas (population of approximately 1.3
million) is conducted in these facilities. All patients who
underwent polysomnography (PSG) or ambulatory mon-
itoring for the presence of OSA were invited to participate
in the study. We excluded non-Alberta residents, patients
previously diagnosed with OSA, and those referred but
did not undergo diagnostic testing.
Obstructive Sleep Apnea
We used polysomnography (PSG) and ambulatory moni-
toring to identify OSA within participants. Although PSG
is considered the 'gold standard' diagnostic test for OSA,
an ambulatory monitoring device has proven to have
excellent agreement, sensitivity and specificity with PSG
[36]. In addition, the use of ambulatory monitoring has
been validated as a clinical management tool [37,38].
We stratified patients by OSA severity, based on their sleep
test results, using the respiratory disturbance index (RDI).
The RDI was defined as the number of apneas and hypop-
neas per hour of sleep. Apnea was defined as a cessation
of airflow for at least 10 seconds. Hypopnea was defined
as an abnormal respiratory event lasting 10 seconds or
more, with at least a 30% reduction in thorocoabdominal
movement or airflow compared to baseline, and associ-
ated with at least a 4% oxygen desaturation. OSA severity
categories included: no OSA (RDI <5 event/hr), mild OSA
(RDI 5–14.9 events/hr), moderate OSA (RDI 15–29.9
events/hr) and severe OSA (RDI ≥ 30 events/hr). This clas-
sification system is well accepted in both clinical practice
and within the medical literature [39,40]. The date of the
sleep study was used to define the index date.
Determination of Co-morbidities and Clinical 
Characteristics from Surveys
Baseline clinical and demographic information was col-
lected for all participants prior to sleep diagnostic testing.
This included: age, sex, height, weight, body mass index
(BMI), neck circumference, and postal code. Each partici-
pant also completed the Epworth Sleepiness Scale (ESS)
[41], a self-administered questionnaire that provides a
measure of daytime sleepiness. Co-morbidity was deter-
mined through the use of a questionnaire administered by
trained personnel within the clinics, and patients were
asked to self-report the presence of nine specific co-mor-
bidities including hypertension, asthma, depression, car-
diac arrhythmia, myocardial infarction, chronic
obstructive pulmonary disease (COPD), diabetes, heart
failure, and stroke. Patients were also required to provide
a list of their current medications at the time of the survey.
This study was approved by the Ethics Review Board of the
University of Calgary, and patients gave written informed
consent to participate in the study.
Determination of Co-morbidities from Administrative 
Data Sources
Using the patient's unique Provincial Health Number
(PHN), the cohort was linked to two Alberta Health and
Wellness administrative databases, the hospitalization
discharge database, and the physician claims database.
For each patient, all hospitalization and physician claims
information was obtained for a two-year period prior to
sleep diagnostic testing.BMC Medical Research Methodology 2009, 9:50 http://www.biomedcentral.com/1471-2288/9/50
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The hospital inpatient data source contains details regard-
ing hospitalizations including admission date, discharge
date, length of stay, 25 diagnostic codes (ICD-10), and 10
procedure codes for each admission. The physician claims
registry contains information on physician services
including dates and location of the visits, diagnostic codes
(ICD-9-CM), provider specialty, and include the majority
of residents in the province except a small proportion of
special population groups (i.e. members of the Armed
Forces, Royal Canadian Mounted Police (RCMP), and fed-
eral inmates – accounting for approximately 1% of the
total population) [42].
Co-morbid conditions were identified within the Alberta
Health and Wellness administrative databases using the
International Classification of Diseases (ICD-9-CM and
ICD-10) definitions for the nine specific co-morbidities.
When available, validated algorithms were used to define
each co-morbid condition (Table 1) [43-48]. These algo-
rithms were further supplemented by the ICD-10 coding
scheme developed by Quan et al. [49]. For co-morbidities
that did not have validated algorithms (specifically
COPD, depression and cardiac arrhythmia), ICD-9-CM
and ICD-10 diagnostic codes were identified within the
ICD-9-CM and ICD-10 manuals [50,51]. Within the
administrative datasets, the condition was considered
present if the algorithm defining the condition was satis-
fied. For example, diabetes was considered present if there
were two or more separate diagnostic codes identifying
diabetes within the physician claims or one or more hos-
pitalization diagnostic codes identifying diabetes within
the a two year period [44]. Co-morbidities that did not
Table 1: ICD-9-CM and ICD-10 Codes to Define Co-morbidity Among Patients Referred for Sleep Diagnostic Testing
Co-morbidities Authors Algorithm ICD-10 diagnostic 
codes
ICD-9-CM diagnostic 
codes
Sensitivity Specificity PPV
Hypertension 
(with and without 
complication)
Tu et al.[43] 2 physician claims in 
3 years
I10.x, I11.x–I13.x, 
I15.x
401.x, 402.x–405.x 73% 95% 87%
Diabetes (with and 
without 
complication)
Hux et al.[44] 1 hospitalization or 
2 physician claims in 
2 years
E10.0-E10.9, E11.0-
E11.9, E12.0-E12.9, 
E13.0-E13.9, E14.0-
E14.9
250.0–250.9 86% 97% 80%
Asthma Huzel et 
al.[45]
1 or more physician 
claims in 2 years
J45.0, J45.1, J45.8, J45.9 490.0, 491.0, 492.0, 493.0 50.9% 98.1% NR
Myocardial 
Infarction
Austin et 
al.[46]
Primary discharge 
diagnosis of AMI in 
hospitalization 
database
I21.x, I22.x, I25.2 410.x 88.8% 92.8% 88.5%
Congestive Heart 
Failure
Lee et al.[47] Primary discharge 
diagnosis of CHF in 
hospitalization 
database
I09.9, I11.0, I13.0, 
I13.2, I25.5, I42.0, 
I42.5–42.9, I43.x, I50.x, 
P29.0
428.x NR NR 94.3%
Cerebrovascular 
Accident/Transient 
Ischemic Attack
Kokotailo 
and Hill[48]
Primary discharge 
diagnosis of stroke 
in hospitalization 
database
H34.1, I63.x, I64.x, 
I61.x, I60.x, G45.x
362.3, 430.x, 431.x, 433.x1, 
434.x1, 435.x, 436
67% 97% 84%
COPD No Validated Algorithm J44 491.21, 493.2, 496 NR NR NR
Depression No Validated Algorithm F20.4, F31.3-F31.5, 
F32.x, F33.x, F34.1, 
F41.2, F43.2
296.2, 296.3, 296.5, 300.4, 
309.x, 311
NR NR NR
Cardiac 
Arrhythmia
No Validated Algorithm I44.1-I44.3, I45.6, 
I45.9, I47.x-I49.x, 
R00.0, R00.1, R00.8, 
T82.1, Z45.0, Z95.0
426.0, 426.1, 426.7, 426.9, 
426.10, 426.12, 427.0–
427.4, 427.6–427.9, 785.0, 
996.01, 996.04, V45.0, 
V53.3
NR NR NR
Abbreviations: NR = Not ReportedBMC Medical Research Methodology 2009, 9:50 http://www.biomedcentral.com/1471-2288/9/50
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have a validated algorithm (depression, COPD and car-
diac arrhythmia) were considered present if at least one
diagnostic code recorded for the condition within either
the physician claims data or hospitalization data was
recorded within the two-year period prior to the index
date. All 3 diagnostic coding fields were used within the
physician claims data and all 25 diagnostic codes within
inpatient hospitalization data. We used diagnostic type
indicators in this data source to restrict conditions to only
those present prior to admission and therefore excluded
any condition that developed while staying in hospital.
Analysis
Patient characteristics were described using mean and
standard deviation for normally distributed variables. In
cases of highly skewed or non-normal distributions, the
median and the inter-quartile range (IQR) were reported.
Means and proportions were compared using analysis of
variance and chi-square tests respectively. In addition,
proportions of patients presenting with specific co-mor-
bidities, identified in the questionnaire, were calculated.
To assess the agreement between self-reported co-morbid-
ity and administrative databases, we calculated the pro-
portion of subjects with each co-morbid condition based
on: self-report only, administrative data sources only,
both self-report and administrative data, and either self-
report or administrative data. To evaluate consistency
between self-report and administrative data the Kappa (κ)
statistic and 95% confidence intervals were calculated.
The Kappa statistic is an index of the degree of agreement
between two raters, and can be thought of as the chance-
corrected proportional agreement; possible values range
from +1 (perfect agreement) to 0 (no agreement above
that expected by chance). Kappa values were defined as: <
0.40 as poor or fair agreement, 0.40–0.60 as moderate
agreement, 0.61–0.80 as substantial agreement, and
0.81–1.00 as almost perfect agreement [52].
In addition, the McNemar's test of paired proportions was
determined. This is a statistical procedure to compare two
dependent or correlated proportions, and is a test of mar-
ginal homogeneity that compares agreement between dis-
cordant pairs. A statistically significant McNemar's test
would indicate a difference between the proportions com-
pared. Finally to assess the validity of the enhanced meas-
ures of co-morbidity an analysis was also performed in
which patients were stratified by severity of OSA to deter-
mine trends in the prevalence of the co-morbid condi-
tions. All statistical analysis was conducted using STATA
10.0 software (Statacorp, College Station, Texas).
Results
Study Participants
From July 2005 to August 2007, 2295 patients were
referred for sleep diagnostic testing, of whom 78 (3.4%)
patients refused to participate and 42 (1.8%) patients
were from out of province and were therefore excluded.
Of the remaining 2175 patients, 26 (1.2%) were excluded
because they were not present in the Alberta Health and
Wellness registry file, for a final study population size of
2149 (Figure 1). Within this study population, 367
patients underwent full overnight polysomnography and
the remainder (n = 1782) had ambulatory monitoring
either through a private home care facility (n = 388) or
through the Alberta Lung Association Sleep Clinic (n =
1394). From the study cohort, 432 (20.1%) patients were
identified as having no OSA, 738 (34.3%) with mild OSA,
443 (20.6%) with moderate OSA and 536 (24.9%) with
severe OSA. Descriptive characteristics of study subjects,
by OSA severity, are presented in Table 2. Overall patients
with severe OSA were more likely to be male, older and
have a higher Epworth Sleepiness Score compared to sub-
jects with lesser degrees of OSA.
Comparison of Co-Morbidity Determined by Self-Report 
and Administrative Data Algorithms
Table 3 presents the prevalence and agreement for co-
morbidities determined by self-report and administrative
data. The most prevalent condition in both self-report and
administrative data was hypertension and depression,
with 35.1% and 27.0% of subjects referred for sleep test-
ing self-reporting the presence of these conditions respec-
tively. The proportions based on self-report and
Table 2: Patient Characteristics
All
(n = 2149)
No OSA
(n = 432)
Mild OSA
(n = 738)
Moderate OSA
(n = 443)
Severe OSA
(n = 536)
p-value*
Male n (%) 1346 (62.6) 197 (45.6) 463 (62.7) 281 (63.4) 405 (75.6) <0.001
Age, yrs mean (SD) 50.1 (12.9) 44.0 (12.9) 50.0 (12.5) 52.8 (12.5) 53.0 (11.9) <0.001
BMI, kg/m2 median (IQR) 31.3
(27.3, 36.6)
27.8
(24.9, 32.2)
30.6
(27.2, 35.4)
32.0
(28.1, 36.8)
34.5
(30.4, 39.8)
<0.001
Epworth Sleepiness Score, mean (SD) 11.3 (5.4) 10.9 (5.1) 10.7 (5.3) 11.4 (5.4) 12.4 (5.5) <0.001
Current Smoker, n (%) 354 (16.5) 89 (20.6) 116 (15.7) 60 (13.5) 89 (16.6) 0.111
Abbreviations: BMI = body mass index; IQR = inter-quartile range; SD = standard deviation
* Chi-squared test, analysis of variance (3 degrees of freedom)BMC Medical Research Methodology 2009, 9:50 http://www.biomedcentral.com/1471-2288/9/50
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Patient Flow Diagram Figure 1
Patient Flow Diagram.
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administrative algorithms differed significantly (McNe-
mar's p value < 0.05) for all conditions except depression
and COPD. There was substantial agreement between self-
report and administrative algorithms for diabetes, with a
κ = 0.79. There was good agreement for hypertension (κ =
0.60), depression (κ = 0.50) and asthma (κ = 0.49). How-
ever COPD, heart failure, myocardial infarction, stroke
and cardiac arrhythmia all demonstrated poor agreement.
Of note, there was a large discrepancy between self-report
and administrative data for the presence of cardiac
arrhythmia (5.7% vs. 30.4%).
When "both" self-reported and administrative measures
of co-morbidity were required to define each condition,
proportions for all nine conditions were much lower
when compared to a definition that required "either" self-
report or administrative measure. For example, the pro-
portion of patients with hypertension was 25.1% when
"both" were used and 43.2% when "either" was used.
Co-Morbidity Measurement by OSA Severity
The prevalence of each of the nine conditions determined
by self-report and administrative algorithms, stratified by
Table 3: Agreement between Self-reported Co-Morbidity and Administrative Measure of Co-Morbidity
Co-morbidity Self-Report Administrative
Algorithms
Present in Both Data 
Sources
Present in Either Data 
Source
Kappa†
(95% CI)
McNemar's††
p-value
Hypertension
n (%)
754
(35.1)
714
(33.2)
539
(25.1)
929
(43.2)
0.60
(0.52, 0.63)
0.0428
Diabetes
n (%)
289
(13.4)
238
(11.1)
214
(10.0)
313
(14.6)
0.79
(0.75, 0.83)
<0.001
Asthma
n (%)
358
(16.7)
247
(11.5)
168
(7.8)
437
(20.3)
0.49
(0.43, 0.54)
<0.001
Myocardial Infarction
n (%)
194
(9.0)
53
(2.5)
37
(1.7)
210
(9.8)
0.27
(0.20, 0.35)
<0.001
Heart Failure
n (%)
72
(3.4)
29
(1.3)
15
(0.7)
86
(4.0)
0.28
(0.17, 0.40)
<0.001
Stroke
n (%)
62
(2.9)
9
(0.4)
8
(0.4)
63
(2.9)
0.22
(0.09, 0.35)
<0.001
No defined Algorithm Self-Report No defined Algorithm* Both Either Kappa
(95% CI)
McNemar's
p value
Depression
n (%)
581
(27.0)
573
(26.7)
364
(16.9)
790
(36.8)
0.50
(0.45, 0.54)
0.6983
Cardiac Arrhythmia
n (%)
123
(5.7)
654
(30.4)
86
(4.0)
691
(32.2)
0.14
(0.10, 0.17)
<0.001
COPD
n (%)
67
(3.1)
77
(3.6)
24
(1.1)
120
(5.6)
0.31
(0.21, 0.41)
0.3074
* At least one physician claim or hospitalization diagnosis in 2 years.
† The Kappa statistic is an index of the degree of agreement between two raters.
†† McNemar's test of paired proportions is a test of marginal homogeneity that compares the agreement between discordant pairs.
Table 4: Self-reported Co-Morbidity and Administrative Measure of Co-Morbidity Stratified by OSA Severity
Self-Report Administrative Algorithms
Co-morbidity No OSA
(n = 432)
Mild OSA
(n = 738)
Moderate OSA
(n = 443)
Severe OSA
(n = 536)
No OSA
(n = 432)
Mild OSA
(n = 738)
Moderate OSA
(n = 443)
Severe OSA
(n = 536)
Hypertension 22.7% 29.1% 42.2% 47.4% 19.2% 27.8% 41.3% 45.3%
Depression 30.1% 28.0% 28.4% 22.0% 29.4% 27.2% 27.8% 22.3%
Diabetes 7.6% 10.6% 11.5% 23.7% 6.7% 8.3% 9.5% 19.8%
Asthma 19.7% 17.1% 17.8% 12.7% 12.3% 10.6% 14.2% 9.9%
COPD 3.2% 2.7% 4.3% 2.6% 3.5% 3.3% 3.4% 4.3%
Myocardial Infarction 4.2% 8.5% 11.1% 11.9% 0.9% 2.0% 1.8% 4.9%
Heart Failure 1.4% 3.1% 2.9% 5.6% 0.5% 1.2% 1.1% 2.4%
Stroke 2.3% 2.2% 2.9% 4.3% 0% 0.1% 0.7% 0.9%
Cardiac
Arrhythmia
4.2% 6.0% 6.5% 6.0% 23.4% 28.7% 35.0% 34.7%BMC Medical Research Methodology 2009, 9:50 http://www.biomedcentral.com/1471-2288/9/50
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OSA severity, are presented in Table 4. Based on self-
report alone, the prevalence of hypertension, diabetes,
and myocardial infarction increased as OSA severity
increased. When using the administrative algorithms, a
similar trend was observed for hypertension, diabetes and
stroke. Table 5 depicts the "enhanced" co-morbidities
based on a combination of either self-report or adminis-
trative data. The prevalence of hypertension, diabetes and
myocardial infarction all increased with increasing OSA
severity (p < 0.001).
Discussion
In this large cohort of patients referred for sleep testing we
determined that patient self-report of nine co-morbid
conditions had varying levels of agreement with that
derived from administrative data. Specifically, agreement
was highest for diabetes and hypertension, and lowest for
cardiac arrhythmia and stroke. An enhanced measure of
co-morbidity using either self-report or administrative
data demonstrated face validity and clinically meaningful
trends of increasing prevalence by OSA severity. These
results suggest that when agreement between data sources
is poor, a combination of sources should be used when
defining co-morbidity in OSA patients, as use of either
source alone may result in an underestimate of the preva-
lence of these conditions. Specifically, using "either" self-
report or administrative measure will increase the sensitiv-
ity of the estimate of co-morbidity.
We found that among patients referred for sleep testing,
self-report of diabetes and hypertension had the highest
agreement with administrative data derived definitions
for these conditions. These findings are similar to those
reported based on administrative data and survey data
from an adult sample extracted from the Canadian Com-
munity Health Survey (CCHS) in Manitoba, Canada.
Agreement between the two sources was highest for diabe-
tes (κ > 0.70) and hypertension (κ > 0.50), and lowest for
non-specific heart disease (κ = 0.38) [30]. Cricelli et al.
also found good agreement between self-reported diabe-
tes and hypertension and administrative data sources
[25]. The consistency of self-reported and administrative
data for these two conditions likely occurs because these
conditions have clear objective criteria for diagnosis and
require ongoing medical treatment. Agreement between
self-reported measures of chronic disease and administra-
tive data is dependent on the condition specifically [30].
We found very poor agreement between self-report and
administrative data for the presence of cardiac arrhythmia
and stroke. Underreporting of cardiac arrhythmia likely
occurred because respondents are not aware of the diag-
noses, or lack of familiarity with this medical term found
on the self-report questionnaire [30]. Though cardiac
arrhythmia is common in patients with OSA with preva-
lence values ranging from 35–48% [13,14], accurate self-
reporting is more likely to occur for conditions that
require frequent contacts with a health professional; car-
diac arrhythmia is not one of these conditions. The
enhanced definition of cardiac arrhythmia in our study is
similar to the known prevalence in this population, and
thus is likely to be an accurate reflection of the prevalence
of this co-morbidity within the cohort (32.2%). The poor
agreement between the two sources for stroke was also an
interesting finding. We speculate that the discrepancies
between administrative data and self-report for identify-
ing stroke are due to the lower sensitivity of the adminis-
trative algorithm (67%), thus underestimating the true
prevalence within this source. Again, the combination of
either source likely provides a more accurate representa-
tion of stroke prevalence in this clinical population.
The measure of co-morbidity using the enhanced combi-
nation of data sources found that as OSA severity
increased, the prevalence of hypertension, diabetes, and
myocardial infarction also increased. This dose-response
Table 5: Enhanced Measure of Co-Morbidity using Either Self-Report or Administrative Databases Stratified by OSA Severity
Either Self-Report or Administrative Database (Enhanced)
Co-morbidity No OSA
(n = 432)
Mild OSA
(n = 738)
Moderate OSA
(n = 443)
Severe OSA
(n = 536)
p-value*
Hypertension 28.0% 36.3% 51.0% 58.6% <0.001
Depression 40.3% 37.5% 38.1% 31.7% 0.12
Diabetes 9.3% 11.9% 12.6% 24.1% <0.001
Asthma 20.8% 21.3% 21.7% 17.5% 0.41
COPD 5.6% 4.7% 6.8% 5.8% 0.56
Myocardial Infarction 4.6% 8.9% 11.5% 13.6% <0.001
Heart Failure 1.6% 3.5% 3.4% 7.1% 0.09
Stroke 2.3% 2.2% 3.2% 4.3% 0.15
Cardiac Arrhythmia 24.8% 31.0% 36.6% 36.0% 0.08
* Chi-squared test (3 degrees of freedom)BMC Medical Research Methodology 2009, 9:50 http://www.biomedcentral.com/1471-2288/9/50
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relationship for these specific conditions by OSA severity
has been documented in previous studies [5,10,53-55]
and provides support for the face validity of our enhanced
measures of co-morbidity.
The results of our study should be interpreted in context
of the study limitations. First, for three of the conditions
of interest (depression, cardiac arrhythmia, and COPD),
validated administrative algorithms were unavailable.
Using an algorithm of at least one physician claim or hos-
pitalization in a two-year period may have resulted in
some misclassification and an over-reporting of these con-
ditions. Secondly, we did not have a gold standard to
determine whether the enhanced measures are more valid
than a single data source alone. However, the increasing
prevalence of conditions by OSA severity, consistent with
that in the literature, does provide evidence of face valid-
ity. Finally, our study was limited to a single geographic
region (Calgary Health Region) and only included
patients referred for sleep diagnostic testing. These
patients likely represent those with more severe morbidity
and will limit the generalizability of these results to other
clinic-based sleep cohorts in North America.
Conclusion
We found that administrative data in combination with
survey data has the potential to create a more complete
measure of the co-morbidity among patients referred for
sleep diagnostic testing, particularly when agreement
between survey and administrative data is poor. Given the
resources required to obtain clinical data, use of data
enhancement with administrative data may be valuable to
other researchers. Although, future studies are required to
validate co-morbidities based on data enhancement, these
results suggest that this methodology can aid in the
adjustment of these coexisting conditions in observa-
tional studies in this area.
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